Why I'm Not Worried About Teladoc's Q2 Earnings Miss

·5-min read
Why I'm Not Worried About Teladoc's Q2 Earnings Miss

As a Teladoc Health (NYSE: TDOC) shareholder, I cringed when I saw the stock's initial sell-off on July 28, the day the company released its second-quarter results last week -- it fell as much as 11.8% before recovering. Although the company's net loss of $0.86 per share was worse than the $0.56 loss analysts were expecting, it was actually a pretty good quarter for the company, and there were many positives to pull from it.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting